Prosecution Insights
Last updated: April 19, 2026

Matrixome Inc.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17923323 CHIMERIC PROTEIN COMPRISING A FIBRINOGEN FRAGMENT AND A LAMININ FRAGMENT AND USE THEREOF EIX, EMILY FAY 1653 Final Rejection Nov 04, 2022

Managing Matrixome Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month